Dare Bioscience, Inc. — Director's Dealing 2017

Jan 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2017-01-06

Reporting Person: GUIFFRE CHRISTOPHERD T (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-06	Stock Option (right to buy)	$0.82	A	150000	Acquired	2027-01-05	Common Stock (150000)	Direct
2017-01-06	Stock Option (right to buy)	$0.82	A	150000	Acquired	2027-01-05	Common Stock (150000)	Direct

Footnotes

F1: This option was granted on January 6, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 1, 2017.

F2: This option was granted on January 6, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019.